Physician profile
Jamey Sarvis
NPI 1912950296
$14,632.23
in general payments reported to CMS, 2019-2025
49 companies · $5,098 in 2025
The $5,098 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.42 · 2020: $640 · 2021: $2,050 · 2022: $1,898 · 2023: $2,176 · 2024: $2,737 · 2025: $5,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,087 · Travel and Lodging: $1,856 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,087.31 |
| Travel and Lodging | $1,855.77 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,797.24 | 2024-2025 | Aquabeam System |
| Medtronic, INC. | $1,141.95 | 2022-2025 | Altaviva, Interstim |
| Janssen Biotech, INC. | $1,120.59 | 2019-2025 | Erleada, Akeega, Carvykti |
| Sumitomo Pharma America, INC. | $1,081.00 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $960.74 | 2020-2025 | Veozah, Myrbetriq, Xtandi |
| Pfizer INC. | $902.85 | 2020-2025 | |
| Abbvie INC. | $791.50 | 2020-2025 | Botox |
| Myriad Genetic Laboratories, INC. | $752.07 | 2021-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $576.46 | 2020-2024 | Xiaflex, Edex, Aveed |
| Dendreon Pharmaceuticals LLC | $536.07 | 2021-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $450.11 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $406.06 | 2020-2025 | Axonics, Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit |
| Amgen INC. | $376.96 | 2020-2024 | Xgeva, Prolia |
| Urogen Pharma, INC. | $314.05 | 2020-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $312.68 | 2021-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $216.17 | 2023 | Da Vinci Surgical System |
| Tolmar Pharmaceuticals, INC. | $209.92 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $186.69 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $166.48 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Tolmar, INC. | $166.33 | 2023-2025 | Eligard, Jatenzo |
| Telix Pharmaceuticals | $163.17 | 2024-2025 | Illuccix |
| Endo USA, INC. | $160.31 | 2024-2025 | Xiaflex, Aveed, Edex |
| Antares Pharma, INC. | $157.61 | 2021-2024 | Xyosted |
| Urovant Sciences INC | $151.59 | 2021-2022 | |
| Allergan, INC. | $128.46 | 2020-2022 | |
| Verity Pharmaceuticals INC. | $118.00 | 2022-2025 | Trelstar |
| Laborie Medical Technologies Corp. | $116.04 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Eclipse, Endosheath Technology |
| Blue Earth Diagnostics | $112.83 | 2021-2024 | |
| Accord Healthcare, INC. | $112.27 | 2023-2025 | |
| Axonics, INC. | $111.68 | 2023-2024 | Axonics, Bulkamid |
| Teleflex LLC | $93.71 | 2023-2025 | Urolift |
| Clarus Therapeutics INC. | $92.37 | 2021 | |
| Olympus America INC. | $74.74 | 2023-2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $71.50 | 2020-2021 | |
| Tempus Ai, INC | $63.82 | 2024 | Xt Cdx |
| Profound Medical Corp. | $54.32 | 2025 | Tulsa-Pro |
| Caris Mpi, INC. | $51.05 | 2025 | Mi Cancer Seek |
| Immunitybio, INC. | $47.13 | 2024 | |
| Cook Medical LLC | $40.69 | 2024 | Cook, Ncircle, Resonance |
| Lsi Solutions INC | $39.90 | 2024 | Jnw Urtrac |
| Sun Pharmaceutical Industries INC. | $35.99 | 2022-2025 | |
| Metuchen Pharmaceuticals | $29.35 | 2020 | |
| Myovant Sciences INC. | $25.87 | 2021 | |
| Progenics Pharmaceuticals, INC. | $22.94 | 2025 | |
| Civco Medical Instruments | $22.81 | 2024 | |
| Mimedx Group, INC. | $19.91 | 2024 | |
| Coloplast Corp | $19.87 | 2024 | |
| Sagent Pharmaceuticals | $15.14 | 2024 | Glydo |
| Kowa Pharmaceuticals America, INC. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamey Sarvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.